Join to View Full Profile
259 E Erie StChicago, IL 60611
Phone+1 312-695-7950
Fax+1 312-695-5747
Dr. Ajroud-Driss is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Illinois College of Medicine at ChicagoResidency, Neurology, 2001 - 2004
National School of Science - Tunisia Faculty of MedicineClass of 1996
McGaw Medical Center of Northwestern UniversityFellowship, Neuromuscular Medicine (Neurology)
Certifications & Licensure
IL State Medical License 2003 - 2026
American Board of Psychiatry and Neurology Neurology- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- International Guillain-Barré Syndrome Outcome Study Start of enrollment: 2012 May 01
- Weekly Steroids in Muscular Dystrophy Start of enrollment: 2019 Jul 01
Publications & Presentations
PubMed
- Risk prediction for ALS using semi-competing risk models with applications to the ALS Natural History Consortium dataset.Andres Arguedas, David Schneck, Erjia Cui, Annette Xenopoulos-Oddsson, Ximena Arcila-Londono
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2025-08-01 - Time-to-event prediction in ALS using a landmark modeling approach, using the ALS Natural History Consortium dataset.David Schneck, Andres Arguedas, Annette Xenopoulos-Oddsson, Ximena Arcila-Londono, Christian Lunetta
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2025-08-01 - Toward therapeutic trials in primary lateral sclerosis.Erica Scirocco, Matti D Allen, Elisa Giacomelli, Senda Ajroud-Driss, Jinsy Andrews
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2025-07-06
Press Mentions
Sean M. Healey & AMG Center Announces Update in ALS Platform Trial with FosigotifatorJanuary 6th, 2025- Advocating to Fight ALSSeptember 21st, 2021
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
